Medicare Enrolled

Dr. Michael Pendola, M.D.

Optician · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3409 WORTH ST, Dallas, TX 75246
2148241730
In practice since 2006 (19 years)
NPI: 1932279577 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pendola from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pendola? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pendola

Dr. Michael Pendola is an optician specialist in Dallas, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Pendola performed 434 Medicare services across 384 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pendola received a total of $21,937 from 47 pharmaceutical and/or device companies across 338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pendola is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 434 Medicare services $21,937 industry payments

Medicare Practice Summary

Medicare Utilization ↗
434
Medicare services
Bottom 31% in TX for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
384
Unique beneficiaries
$138
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~23 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 110 $90 $238
New patient office visit (45-59 min) 47 $124 $310
Hospital follow-up visit, moderate complexity 44 $61 $186
Colonoscopy with biopsy 43 $157 $1,495
Office visit, established patient (20-29 min) 34 $65 $168
New patient office visit (30-44 min) 29 $78 $207
Initial hospital admission, high complexity 26 $131 $517
New patient office visit, complex (60-74 min) 21 $148 $409
Colorectal cancer screening; colonoscopy on individual at high risk 20 $179 $528
Diagnostic exam of rectum and lower large bowel using an endoscope 19 $96 $437
Office visit, established patient, complex (40-54 min) 19 $142 $335
Partial removal of large bowel and reattachment to rectum using an endoscope 11 $1,306 $5,909
Initial hospital admission, moderate complexity 11 $105 $352
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,937
Total received (2018-2024)
Avg $3,134/year across 7 years
Top 9% in TX for optician
47
Companies
338
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,096 (68.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,841 (31.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$847
2023
$6,840
2022
$10,129
2021
$1,112
2020
$644
2019
$907
2018
$1,459

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Intuitive Surgical, Inc.
$15,145
ABBVIE INC.
$1,489
Takeda Pharmaceuticals U.S.A., Inc.
$916
Merck Sharp & Dohme Corporation
$476
THD America, Inc.
$444
AbbVie Inc.
$389
Stryker Corporation
$356
AbbVie, Inc.
$267
TELA Bio, Inc.
$223
PFIZER INC.
$215
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$166
Organon LLC
$133
Ferring Pharmaceuticals Inc.
$122
Ethicon US, LLC
$118
TETRAPHASE PHARMACEUTICALS, INC.
$114
Medical Device Business Services, Inc.
$112
GI Supply, Inc.
$108
Merck Sharp & Dohme LLC
$106
Medtronic, Inc.
$89
ACELL, INC.
$86
Braintree Laboratories, Inc.
$81
Mallinckrodt Enterprises LLC
$80
Mallinckrodt LLC
$80
Integra LifeSciences Corporation
$55
Allergan, Inc.
$51
Axonics, Inc.
$46
Mallinckrodt Hospital Products Inc.
$46
Synergy Pharmaceuticals Inc
$40
Innovation Technologies Inc
$39
Medtronic USA, Inc.
$39
Shire North American Group Inc
$27
Axonics Modulation Technologies, Inc.
$27
Amgen Inc.
$23
Allergan Inc.
$22
Avanos Medical
$22
BOSTON SCIENTIFIC CORPORATION
$21
Cumberland Pharmaceuticals, Inc.
$21
AIMMUNE THERAPEUTICS, INC.
$19
INTUITIVE SURGICAL, INC.
$17
DAVOL INC.
$17
AstraZeneca Pharmaceuticals LP
$16
Acacia Pharma Inc
$15
NESTLE HEALTHCARE NUTRITION INC.
$15
Organon Llc
$14
Covidien LP
$13
Pacira Pharmaceuticals Incorporated
$12
QOL Medical, LLC
$4
Top 3 companies account for 80.0% of total payments
Associated products mentioned in payments ›
APRISO · AVSOLA · Amitiza · Axonics · Axonics r-SNM System · BIOFIX · BRIDION · BYFAVO · CALDOLOR · CHANTIX · CIMZIA · CLENPIQ · DAVINCI XI · DIFICID · Da Vinci Surgical System · ECHELON ENDOPATH · EEA · ELIQUIS · ENSEAL Product Family · ENTEREG · ENTYVIO · Echelon Circular · Entyvio · Exparel · GATTEX · HADLIMA · HUMIRA · Humira · INTERSTIM · IRRISEPT · Integra · Irrisept · LIGASURE · MOTEGRITY · MOVANTIK · MOVIPREP · NEXPLANON · OFIRMEV · ON-Q* PUMP AND ACCESSORIES · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · Ovitex · PINPOINT · RENFLEXIS · RESOLUTION CLIP · RINVOQ · SIGNIA · SKYRIZI · SPY TECHNOLOGY · SPY-PHI SYSTEM · STRATTICE · SUPREP · SURGICEL Family of Absorbable Hemostats · SURGIMEND · SUTAB · Signia · Sucraid · TRULANCE · Trulance · UCERIS TABLETS · VERIFY · VITAGEL · VOWST · XIFAXAN · Xerava · ZENPEP · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for optician in TX.

Equivalent to $5,055 per 100 Medicare services performed
Looking for an optician specialist in Dallas?
Compare opticians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
500
Per 100K population
19.2
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pendola is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 9% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Pendola experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pendola performed 110 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pendola receive payments from pharmaceutical companies?
Yes. Dr. Pendola received a total of $21,937 from 47 companies across 338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pendola's costs compare to other opticians in Dallas?
Dr. Pendola's average Medicare payment per service is $138. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pendola) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →